Literature DB >> 4448555

Propranolol therapy in essential hypertension. Observations on predictability of therapeutic response.

L Hansson, A J Zweifler, S Julius, C N Ellis.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1974        PMID: 4448555

Source DB:  PubMed          Journal:  Int J Clin Pharmacol        ISSN: 0300-9718


× No keyword cloud information.
  16 in total

1.  Clinical pharmacokinetics of beta-adrenoreceptors blockers.

Authors:  G Johnsson; C G Regårdh
Journal:  Drugs       Date:  1976       Impact factor: 9.546

2.  The description and prediction of antihypertensive drug response: an individualised approach.

Authors:  R Donnelly; P A Meredith; H L Elliott
Journal:  Br J Clin Pharmacol       Date:  1991-06       Impact factor: 4.335

Review 3.  The second Lilly Prize Lecture, University of Newcastle, July 1977. beta-Adrenergic receptor blockade in hypertension, past, present and future.

Authors:  B N Prichard
Journal:  Br J Clin Pharmacol       Date:  1978-05       Impact factor: 4.335

Review 4.  The therapeutic dilemma of hypertension in the elderly.

Authors:  S Julius
Journal:  Drugs       Date:  1988       Impact factor: 9.546

5.  Influence of metoprolol, alone and in combination with a thiazide diuretic, on blood pressure, plasma volume, extracellular volume and glomerular filtration rate in essential hypertension.

Authors:  S Rasmussen; K Rasmussen
Journal:  Eur J Clin Pharmacol       Date:  1979-06-12       Impact factor: 2.953

6.  Long term treatment of moderate hypertension with the beta1-receptor blocking agent metoprolol. I. Effect on maximal working capacity, plasma catecholamines and renin, Urinary aldosterone, blood pressure and pulse rate under basal conditions.

Authors:  B G Hansson; J F Dymling; H Hedeland; U L Hulthén
Journal:  Eur J Clin Pharmacol       Date:  1977-04-20       Impact factor: 2.953

7.  Individual factors influencing the response to a beta-adrenergic blocking agent given alone and in combination with a diuretic on arterial hypertension.

Authors:  O L Pedersen; E Mikkelsen
Journal:  Eur J Clin Pharmacol       Date:  1979-11       Impact factor: 2.953

Review 8.  The management of hypertension.

Authors:  B N Prichard; C W Owens
Journal:  Br J Clin Pharmacol       Date:  1986       Impact factor: 4.335

9.  Plasma concentrations of propranolol in patients with essential hypertension.

Authors:  A Lehtonen; J Kanto; T Kleimola
Journal:  Eur J Clin Pharmacol       Date:  1977-03-11       Impact factor: 2.953

Review 10.  Clinical pharmacokinetics and kinetic-dynamic relationships of dilevalol and labetalol.

Authors:  R Donnelly; G J Macphee
Journal:  Clin Pharmacokinet       Date:  1991-08       Impact factor: 6.447

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.